ACADIA PHARMACEUTICALS INC. Expense Breakdown
No Expense Breakdown for ACAD on this site yet.
- 2026-06-30: Reportable Segment, Aggregation before Other Operating $12.79M.
- 2025-06-30: Reportable Segment, Aggregation before Other Operating $8.38M.
Source checked: the stored Expense Breakdown page for ACAD.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Reportable Segment, Aggregation before Other Operating |
|---|
| 2026-06-30 | $12.79M |
|---|
| 2025-06-30 | $8.38M |
|---|
Income Tax Expense (Benefit): each quarter (3 month)
| Quarter end | Reportable Segment, Aggregation before Other Operating |
|---|
| 2026-06-30 | $14.97M |
|---|
| 2025-06-30 | $13.54M |
|---|
Research and development: each quarter (3 month)
| Quarter end | Reportable Segment, Aggregation before Other Operating |
|---|
| 2026-06-30 | $81.56M |
|---|
| 2025-06-30 | $77.95M |
|---|
Selling, General and Administrative Expense: each quarter (3 month)
| Quarter end | Reportable Segment, Aggregation before Other Operating |
|---|
| 2026-06-30 | $160.25M |
|---|
| 2025-06-30 | $133.51M |
|---|